Literature DB >> 24980090

Re-excision rates of invasive ductal carcinoma with lobular features compared with invasive ductal carcinomas and invasive lobular carcinomas of the breast.

David P Arps1, Julie M Jorns, Lili Zhao, Jessica Bensenhaver, Celina G Kleer, Judy C Pang.   

Abstract

BACKGROUND: Invasive ductal carcinoma (IDC) with lobular features (IDC-L) is not recognized as a subtype of breast cancer. We previously showed that IDC-L may be a variant of IDC with clinicopathological characteristics more similar to invasive lobular carcinoma (ILC). We sought to determine the re-excision rates of IDC-L compared with ILC and IDC, and the feasibility of diagnosing IDC-L on core biopsies.
METHODS: Surgical procedure, multiple tumor foci, tumor size, and residual invasive carcinoma on re-excision were recorded for IDC-L (n = 178), IDC (n = 636), and ILC (n = 251). Re-excision rates were calculated by excluding mastectomy as first procedure cases and including only re-excisions for invasive carcinoma. Slides of correlating core biopsies for IDC-L cases initially diagnosed as IDC were re-reviewed.
RESULTS: For T2 tumors (2.1-5.0 cm), re-excision rates for IDC-L (76 %) and ILC (88 %) were higher than that for IDC (42 %) (p = 0.003). Multiple tumor foci were more common in IDC-L (31 %) and ILC (26 %) than IDC (7 %) (p < 0.0001), which was a significant factor in higher re-excision rates when compared with a single tumor focus (p < 0.001). Ninety-two of 149 patients (62 %) with IDC-L were diagnosed on core biopsies. Of the 44 patients initially diagnosed as IDC, 30 were re-reviewed, of which 24 (80 %) were re-classified as IDC-L.
CONCLUSIONS: Similar to ILC, re-excision rates for IDC-L are higher than IDC for larger tumors. Patients may need to be counseled about the higher likelihood of additional procedures to achieve negative margins. This underscores the importance of distinguishing IDC-L from IDC on core biopsies.

Entities:  

Mesh:

Year:  2014        PMID: 24980090     DOI: 10.1245/s10434-014-3871-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  5 in total

1.  Surgical Options and Locoregional Recurrence in Patients Diagnosed with Invasive Lobular Carcinoma of the Breast.

Authors:  Yasuaki Sagara; William T Barry; Melissa Anne Mallory; Ines Vaz-Luis; Fatih Aydogan; Jane E Brock; Eric P Winer; Mehra Golshan; Otto Metzger-Filho
Journal:  Ann Surg Oncol       Date:  2015-04-18       Impact factor: 5.344

Review 2.  New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancers.

Authors:  Armel Hervé Nwabo Kamdje; Paul Faustin Seke Etet; Lorella Vecchio; Richard Simo Tagne; Jeremie Mbo Amvene; Jean-Marc Muller; Mauro Krampera; Kiven Erique Lukong
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

3.  Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers.

Authors:  Marc B I Lobbes; Ingeborg J H Vriens; Annelotte C M van Bommel; Grard A P Nieuwenhuijzen; Marjolein L Smidt; Liesbeth J Boersma; Thijs van Dalen; Carolien Smorenburg; Henk Struikmans; Sabine Siesling; Adri C Voogd; Vivianne C G Tjan-Heijnen
Journal:  Breast Cancer Res Treat       Date:  2017-01-28       Impact factor: 4.872

4.  Invasive lobular carcinoma: clinicopathological features and subtypes.

Authors:  Sabine Danzinger; Nora Hielscher; Miriam Izsó; Johanna Metzler; Carmen Trinkl; Christian Pfeifer; Kristina Tendl-Schulz; Christian F Singer
Journal:  J Int Med Res       Date:  2021-06       Impact factor: 1.671

5.  Success rates of re-excision after positive margins for invasive lobular carcinoma of the breast.

Authors:  Merisa L Piper; Jasmine Wong; Kelly Fahrner-Scott; Cheryl Ewing; Michael Alvarado; Laura J Esserman; Rita A Mukhtar
Journal:  NPJ Breast Cancer       Date:  2019-09-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.